Excelera Plus 7-Year review

For the right buyer, yes. I think this is a solid annuity for someone who wants a guaranteed floor rate with genuine, no-cost upside potential, and who has already decided this money is untouchable for seven years regardless of what happens. It's a much tougher fit for someone who wants any kind of penalty-free access along the way, or who isn't comfortable with a B++-rated carrier holding their money for that long.

The main draw is the combination: a guaranteed 4.00% fixed rate for the full seven years, plus a free chance at something better if the S&P 500 does well over that same stretch. Because the indexed alternative only replaces the fixed accumulation when it's higher, there's no scenario where bundling it makes the contract worse — it's a one-way bet layered on top of a guarantee. A secondary reason someone buys this specific duration rather than the 3-year or 5-year version is the participation rate itself: at 80%, it's meaningfully richer than the shorter terms in the same family, so a buyer who's already comfortable locking up money for seven years gets paid extra for that patience in the form of a bigger equity kicker, not just a longer commitment.

I think this is best for someone with a genuine seven-year (or longer) time horizon on this specific pool of money — retirement dollars they've already earmarked and won't need for emergencies, a home purchase, or anything else in between. It also fits someone who's comfortable with a smaller carrier rated B++ rather than insisting on an A- or better rating, since Revol One sits below that line. It's a poor fit for anyone who wants even modest penalty-free access during the term, anyone shopping primarily on carrier strength, or anyone who'd rather split the same decision across the 3-year or 5-year version of this same product to keep more flexibility.

You're not buying direct S&P 500 exposure, and you're not buying a product that pays out annually based on index performance. You're buying a seven-year fixed annuity with a guaranteed declared rate, plus a built-in feature that compares your fixed-rate outcome to a single, one-time index-linked calculation done only at the very end of the term — and keeps whichever number is bigger. In practice, that means you're buying certainty (the 4.00% floor) with a lottery ticket bolted on top (the 80% participation index alternative), not a market-tracking investment.

Excelera Plus 7-Year is a fixed annuity (MYGA) at its core, but every contract comes standard with an additional feature the carrier calls the MYGIA rider — short for "Multi-Year Guarantee with Indexed Alternative." It's automatically included on every Excelera Plus contract at no extra cost; there's no separate election and no disclosed rider fee.

Here's the mechanism. Revol One declares a fixed rate — currently 4.00% — guaranteed for the full seven-year term. That builds a Guaranteed Fixed Rate Accumulation Value the ordinary way, compounding every year. At the same time, the contract tracks a second, parallel number: an Index Linked Accumulation Value based on the S&P 500. Unlike a typical fixed indexed annuity that credits interest annually, this measurement happens only once, at the very end of the seven-year term — it compares where the S&P 500 started against where it ends, over the full seven years, with no annual resets and no averaging along the way. That single-point comparison is then multiplied by the participation rate, currently 80% (with a 10% guaranteed minimum if the current rate is ever reduced), with no cap and no spread reducing it further.

At the end of year seven, you get whichever number is larger — the guaranteed fixed accumulation or the index-linked figure. If the S&P 500 has a strong seven-year run, the indexed side can meaningfully beat the 4.00% fixed rate. If it doesn't, you still get the fixed rate you were promised. There's one important catch: taking any withdrawal other than an IRS RMD during the term voids the indexed comparison entirely for that term, and you fall back to the fixed-rate accumulation only — another reason this product only really works if you don't touch the money at all for seven years.

Given how illiquid this contract is for seven straight years, the features that matter most beyond the crediting formula are the ones that protect you if something goes wrong along the way — and Revol One includes two, both at no additional charge.

First, the death benefit is a true full-value benefit: your beneficiaries receive the accumulation value at death, plus any positive market value adjustment, with surrender charges waived entirely and no reduction for a negative MVA. In plain terms, dying doesn't trigger a penalty here, and if rates have moved in your favor, your heirs can actually receive more than the account's face value. Second, the contract includes built-in Nursing Home and Terminal Illness waivers (not the same as long-term care insurance, and not available in every state) that waive surrender charges and MVA if you're confined to a nursing home for at least 90 days or are certified terminally ill. Combined with the fact that IRS RMDs are always penalty-free, these features mean the worst-case liquidity scenarios — death, serious illness, or a required distribution — are all handled without cost, even though ordinary discretionary withdrawals are not.

This is the toughest liquidity structure in Revol One's own Excelera Plus family, and it's worth weighing carefully before committing. There is no penalty-free partial withdrawal available at any point during the initial seven-year guarantee period — Wink's own product profile lists this plainly as "N/A." IRS Required Minimum Distributions are the one standing exception; those can always be taken without triggering a surrender charge or MVA. Beyond RMDs, though, any withdrawal during the term does double duty as a penalty: you pay the applicable surrender charge and MVA, and you also forfeit the indexed crediting alternative for that entire term, falling back to the fixed-rate accumulation only.

At the end of the initial term, a 30-day window opens during which the full contract can be surrendered penalty-free. Miss that window, and the contract automatically renews for one additional seven-year term at newly declared rates. Only in that renewal term does a more typical MYGA feature appear — 10% of the accumulation value can be withdrawn penalty-free each year. No further renewals are permitted after that second term. The surrender charge schedule during each guarantee period is 9%, 8%, 7%, 6%, 5%, 4%, 3%, and an MVA can apply on top of that on any non-RMD withdrawal.

There's no explicit fee to point to here — no mortality and expense charge, no product fee, no annual contract fee, and no separate charge for the MYGIA rider or the nursing home/terminal illness waivers. The tradeoffs on this product are structural rather than fee-based, and there are three worth naming plainly.

First, the total illiquidity: going seven full years without any penalty-free access beyond an RMD is a real commitment, and it's the steepest ask anywhere in Revol One's own product lineup. Second, the index measurement itself is a single snapshot taken at the end of the term rather than an average — so the specific date your contract matures matters more here than it would in a product that credits interest annually or averages multiple points. A market downturn in year seven specifically could mean the indexed alternative never beats the fixed rate, even if the index did well for most of the term. Third, Revol One Insurance Company carries an A.M. Best rating of B++ (Good), below the A- threshold we generally like to see for a buyer's longest-duration commitment — a seven-year lockup is exactly the kind of contract where carrier strength matters most, since you have no ability to exit early if something changes.

Legal Entity: Revol One Insurance Company

A.M. Best Rating: B++ (Good); Long-Term Issuer Credit Rating bbb (Good); Outlook Stable (as of 3/27/2024)